Myriad Genetics Blog Breast Cancer Risk Assessment and Preventive Therapy Breast Cancer Risk Assessment and Preventive Therapy November 7, 2022 This program will evaluate various risk assessment methods and focus on risk reducing therapies for patients with an increased risk of breast cancer. Learning Objectives Evaluate current breast cancer risk assessment methods including germline genetics, polygenic risk scores, and risk modeling. Examine an evidence-based overview of endocrine therapy for breast cancer prevention. Summarize a practice approach to risk stratification and management for patients with general, moderate, and high risk of developing breast cancer. Presenter: Holly Pederson, MD This nursing continuing professional development activity is approved for 1.25 contact hours from Oregon Nurses Association (ONA), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). Contact hours will be awarded to participants who view the entire program recording and complete the post-activity survey. Click here after viewing the webinar to complete the survey: Take Survey Please pay close attention to the instructions for receiving your certificate at the end of this survey. Once you have completed this survey in entirety you will have an option to print or save the image of the certificate. We recommend that you complete this from a desktop or your laptop computer for best quality and options for saving this file. Please read the instructions below carefully to obtain your certificate. Please right click on the image of the certificate below and select “save as an image”. You can name the file and save to your computer to access later or to print. If you encounter an error message when downloading to your computer, right click the download tab and click “resume”. This should correct this issue. IMPORTANT: You must save the image at this time to obtain this certificate for your records. Certificates will not be emailed. ***You must complete the webinar and survey no later than October 17th, 2024 to claim credit*** Myriad Genetics Lab, a diagnostic lab that does not sell proprietary products, is an eligible organization according to the American Nurses Credentialing Center criteria. There are no relevant financial relationships with any individuals in the position to control content for this educational activity.